Literature DB >> 2036331

The role of neuropeptides in cardiovascular regulation.

D Ganten1, M Paul, R E Lang.   

Abstract

During the past few years more than 30 novel, biologically active peptides have been discovered. Some are produced in endocrine glands and circulate as hormones in the blood; others are contained in the enterochromaffin cells of the gut and may be involved in the regulation of intestinal functions. The vast majority of new peptides, however, have been detected in the central and peripheral nervous systems, where they are synthesized in distinct neurons and stored in neurovesicles. Many of these neuropeptides may be involved in circulatory regulation. There is evidence supporting such a role, especially for centrally located angiotensin, opioid peptides, substance P, neuropeptide Y (NPY), vasopressin, atrial natriuretic peptide (ANP), kinins, corticotropin releasing factor, bombesin, and somatostatin. In this review we discuss the cardiovascular actions of angiotensin, neuropeptide Y, and calcitonin gene related peptide.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 2036331     DOI: 10.1007/bf03029807

Source DB:  PubMed          Journal:  Cardiovasc Drugs Ther        ISSN: 0920-3206            Impact factor:   3.727


  101 in total

1.  Regional vasodilator actions of calcitonin gene-related peptide in conscious SHR.

Authors:  R W Lappe; J A Todt; R L Wendt
Journal:  Peptides       Date:  1987 Jul-Aug       Impact factor: 3.750

2.  Angiotensin synthesis in the brain and increased turnover in hypertensive rats.

Authors:  D Ganten; K Hermann; C Bayer; T Unger; R E Lang
Journal:  Science       Date:  1983-08-26       Impact factor: 47.728

3.  Effects of neuropeptide Y (NPY) on isolated guinea-pig heart.

Authors:  C Wahlestedt; B Wohlfart; R Håkanson
Journal:  Acta Physiol Scand       Date:  1987-04

4.  Effects of central and peripheral angiotensin blockade in hypertensive rats.

Authors:  J F Mann; M I Phillips; R Dietz; H Haebara; D Ganten
Journal:  Am J Physiol       Date:  1978-05

5.  Regulation of neuropeptide Y (NPY) binding by guanine nucleotides in the rat cerebral cortex.

Authors:  A Undén; T Bartfai
Journal:  FEBS Lett       Date:  1984-11-05       Impact factor: 4.124

6.  Biological actions of human and rat calcitonin and calcitonin gene-related peptide.

Authors:  H J Lenz; J E Rivier; M R Brown
Journal:  Regul Pept       Date:  1985-10

7.  Perivascular peptides relax cerebral arteries concomitant with stimulation of cyclic adenosine monophosphate accumulation or release of an endothelium-derived relaxing factor in the cat.

Authors:  L Edvinsson; B B Fredholm; E Hamel; I Jansen; C Verrecchia
Journal:  Neurosci Lett       Date:  1985-07-31       Impact factor: 3.046

8.  Localisation of neuropeptide Y in nerves of the rat cardiovascular system and the effect of 6-hydroxydopamine.

Authors:  J M Allen; J M Polak; J Rodrigo; K Darcy; S R Bloom
Journal:  Cardiovasc Res       Date:  1985-09       Impact factor: 10.787

9.  Organization of angiotensin II immunoreactive cells and fibers in the rat central nervous system. An immunohistochemical study.

Authors:  R W Lind; L W Swanson; D Ganten
Journal:  Neuroendocrinology       Date:  1985-01       Impact factor: 4.914

10.  Angiotensin II-induced stimulation of voltage-dependent Ca2+ currents in an adrenal cortical cell line.

Authors:  J Hescheler; W Rosenthal; K D Hinsch; M Wulfern; W Trautwein; G Schultz
Journal:  EMBO J       Date:  1988-03       Impact factor: 11.598

View more
  2 in total

1.  Restoration of depressed prostanoid-induced ileal contraction in spontaneously hypertensive rats by dietary fish oil.

Authors:  Glen S Patten; Michael J Adams; Julie A Dallimore; Paul F Rogers; David L Topping; Mahinda Y Abeywardena
Journal:  Lipids       Date:  2005-01       Impact factor: 1.880

2.  Sympathetic activation after two weeks of nifedipine treatment in primary Raynaud's patients and controls.

Authors:  J Leppert; H Nilsson; U Myrdal; L Edvinsson; T Hedner; I Ringqvist
Journal:  Cardiovasc Drugs Ther       Date:  1993-12       Impact factor: 3.727

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.